TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assessment of the Efficacy of Early Intrauterine Tamponade With a Belfort-Dildy Balloon Obstetric Tamponade System in the Treatment of Immediate Postpartum Hemorrhage
Brief Summary: The purpose of this study is to evaluate the impact of early intrauterine tamponade with a Belfort-Dildy balloon catheter in immediate postpartum hemorrhage(IPPH) after vaginal delivery and refractory to first-line uterotonic treatment, ie performed at the same time as second line uterotonic treatment, as compared tolate intrauterine tamponade performed in case of failure of second line uterotonic treatment, on the final severity of PPH. ).


Options:
A: Arm Label: Early Belfort-Dildy balloon device; Type: EXPERIMENTAL; Interventions: Device: Early Belfort-Dildy Balloon | Arm Label: Late Belfort-Dildy balloon device; Type: OTHER; Interventions: Device: Late Belfort-Dildy balloon | Intervention Type: DEVICE; Name: Early Belfort-Dildy Balloon; Assigned to Arm(s): Early Belfort-Dildy balloon device | Intervention Type: DEVICE; Name: Late Belfort-Dildy balloon; Assigned to Arm(s): Late Belfort-Dildy balloon device
B: Arm Label: Amr Maneuver; Type: EXPERIMENTAL; Interventions: Procedure: Amr maneuver | Arm Label: Active management alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Amr maneuver; Assigned to Arm(s): Amr Maneuver
C: Arm Label: Bakri Balloon with abdominal traction stitch; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Abdominal traction stitch, Device: Bakri Balloon | Arm Label: Bakri Balloon without abdominal traction stitch; Type: EXPERIMENTAL; Interventions: Device: Bakri Balloon | Intervention Type: PROCEDURE; Name: Abdominal traction stitch; Assigned to Arm(s): Bakri Balloon with abdominal traction stitch | Intervention Type: DEVICE; Name: Bakri Balloon; Assigned to Arm(s): Bakri Balloon with abdominal traction stitch, Bakri Balloon without abdominal traction stitch
D: Arm Label: Tampostat; Type: EXPERIMENTAL; Interventions: Device: Tampostat | Arm Label: Condom catheter tamponade; Type: ACTIVE_COMPARATOR; Interventions: Device: Condom catheter tamponade | Intervention Type: DEVICE; Name: Tampostat; Assigned to Arm(s): Tampostat | Intervention Type: DEVICE; Name: Condom catheter tamponade; Assigned to Arm(s): Condom catheter tamponade

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions?
Brief Summary: Patients with primary hyperparathyroidism (pHPT) often present with fatigue, psychological and cognitive symptoms. Improvement in these symptoms after parathyroid adenomectomy (PTX) has been reported. But physicians lack a method to attribute the symptoms to pHPT and to predict the reversibility after PTX.

This study aims to evaluate short-term calcimimetic treatment as a tool for predicting the outcome of PTX on muscle strength, quality of life, psychological symptoms, and cognitive function in patients with pHPT.

Material and Methods: 118 patients scheduled for PTX at Karolinska University Hospital, Sweden, will have a four week treatment with calcimimetics (Mimpara®) before undergoing surgery. Biochemicals, muscle strength, quality of life, psychological symptoms and cognitive function will be analysed at baseline, after four week follow-up and postoperatively.

Hypothesis: The outcome of short-term calcimimetic treatment can predict the outcome of PTX on muscle strength, quality of life, psychological symptoms, and cognitive function in patients with pHPT


Options:
A: Arm Label: Early parathyroidectomy group; Type: EXPERIMENTAL; Interventions: Procedure: Early parathyroidectomy group (EPTX-group) | Arm Label: Late parathyroidectomy group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Early parathyroidectomy group (EPTX-group); Assigned to Arm(s): Early parathyroidectomy group
B: Arm Label: cholecalciferol and calcium carbonate; Type: EXPERIMENTAL; Interventions: Drug: calcium carbonate | Arm Label: calciumcarbonate; Type: ACTIVE_COMPARATOR; Interventions: Drug: cholecalciferol and calcium carbonate | Intervention Type: DRUG; Name: cholecalciferol and calcium carbonate; Assigned to Arm(s): calciumcarbonate | Intervention Type: DRUG; Name: calcium carbonate; Assigned to Arm(s): cholecalciferol and calcium carbonate
C: Arm Label: Cinacalcet; Type: EXPERIMENTAL; Interventions: Drug: Cinacalcet, Procedure: parathyroid adenomectomy | Intervention Type: DRUG; Name: Cinacalcet; Assigned to Arm(s): Cinacalcet | Intervention Type: PROCEDURE; Name: parathyroid adenomectomy; Assigned to Arm(s): Cinacalcet
D: N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Addition of Evacetrapib to Atorvastatin Compared to Placebo, High Intensity Atorvastatin, and Atorvastatin With Ezetimibe to Evaluate LDL-C Lowering in Patients With Primary Hyperlipidemia - The ACCENTUATE Study
Brief Summary: The purpose of the ACCENTUATE study is to evaluate whether the study drug known as evacetrapib is effective in treating participants with high cholesterol and atherosclerotic cardiovascular disease (ASCVD) and/or diabetes.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: simvastatin, Drug: atorvastatin | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: ezetimibe (+) simvastatin | Intervention Type: DRUG; Name: ezetimibe (+) simvastatin; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: simvastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: atorvastatin; Assigned to Arm(s): 1
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluvastatin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pravastatin | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pitavastatin | Arm Label: 4; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin | Intervention Type: DRUG; Name: Fluvastatin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Pravastatin; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Pitavastatin; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): 4
C: Arm Label: EZ/Simva; Type: EXPERIMENTAL; Interventions: Drug: ezetimibe (plus simvastatin) | Arm Label: Placebo/Simva; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo (plus simvastatin) | Intervention Type: DRUG; Name: ezetimibe (plus simvastatin); Assigned to Arm(s): EZ/Simva | Intervention Type: DRUG; Name: placebo (plus simvastatin); Assigned to Arm(s): Placebo/Simva
D: Arm Label: Atorvastatin + Evacetrapib; Type: EXPERIMENTAL; Interventions: Drug: Evacetrapib, Drug: Atorvastatin, Drug: Placebo | Arm Label: Atorvastatin 80 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo | Arm Label: Atorvastatin + Ezetimibe; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Ezetimibe, Drug: Placebo | Arm Label: Atorvastatin 40 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atorvastatin, Drug: Placebo | Intervention Type: DRUG; Name: Evacetrapib; Assigned to Arm(s): Atorvastatin + Evacetrapib | Intervention Type: DRUG; Name: Atorvastatin; Assigned to Arm(s): Atorvastatin + Evacetrapib, Atorvastatin + Ezetimibe, Atorvastatin 40 mg, Atorvastatin 80 mg | Intervention Type: DRUG; Name: Ezetimibe; Assigned to Arm(s): Atorvastatin + Ezetimibe | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Atorvastatin + Evacetrapib, Atorvastatin + Ezetimibe, Atorvastatin 40 mg, Atorvastatin 80 mg

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Alcohol, Suicide, and HIV Prevention for Teens in Mental Health Treatment
Brief Summary: This study examines whether an integrated alcohol/substance abuse, suicide, and HIV prevention protocol is associated with lower onset and frequency of alcohol and other drug use, suicidal behavior, and high risk sexual behavior among adolescents receiving community based mental health care.


Options:
A: Arm Label: Prevention Program; Type: EXPERIMENTAL; Interventions: Behavioral: Prevention program | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prevention program; Assigned to Arm(s): Prevention Program
B: Arm Label: Control (volitional help sheet); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Volitional help sheet | Arm Label: Intervention (volitional help sheet); Type: EXPERIMENTAL; Interventions: Behavioral: Volitional help sheet | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Control (volitional help sheet) | Intervention Type: BEHAVIORAL; Name: Volitional help sheet; Assigned to Arm(s): Intervention (volitional help sheet)
C: Arm Label: SAFETY I; Type: EXPERIMENTAL; Interventions: Behavioral: SAFETY | Arm Label: SAFETY II; Type: EXPERIMENTAL; Interventions: Behavioral: SAFETY | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced usual care | Intervention Type: BEHAVIORAL; Name: SAFETY; Assigned to Arm(s): SAFETY I, SAFETY II | Intervention Type: BEHAVIORAL; Name: Enhanced usual care; Assigned to Arm(s): Control
D: Arm Label: ASSIP + TAU goup; Type: EXPERIMENTAL; Interventions: Other: ASSIP | Arm Label: TAU; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: ASSIP; Assigned to Arm(s): ASSIP + TAU goup

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Nurse-led Care Program on Quality of Life and Health Care Utilization for Cancer Patients in a Chemotherapy Day Center: A Randomized Controlled Trial
Brief Summary: A nurse-led care program for cancer patients receiving chemotherapy in an outpatient setting was formulated. The aim of the study was to assess the effect of this nurse-led care program on cancer patients who received neo-adjuvant/adjuvant chemotherapy in a chemotherapy day center in terms of quality of life, symptom experiences, self-efficacy, health care utilization, and satisfaction with care. Specifically, the objectives are:

* To compare the differences of health care utilization between the two arms.
* To compare the differences of cancer patients' satisfaction with care between the two arms.
* To explore the experiences of cancer patients in the intervention arm.
* To understand the experiences of the intervention nurses of the program and their opinions on further development.


Options:
A: Arm Label: MBSR self care program including weekly sessions; Type: EXPERIMENTAL; Interventions: Other: MBSR | Arm Label: MBSR self care program; Type: EXPERIMENTAL; Interventions: Other: MBSR | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: MBSR; Assigned to Arm(s): MBSR self care program, MBSR self care program including weekly sessions
B: Arm Label: Nurse-led care; Type: EXPERIMENTAL; Interventions: Behavioral: Nurse-led care, Behavioral: Routine care | Arm Label: Routine care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Routine care | Intervention Type: BEHAVIORAL; Name: Nurse-led care; Assigned to Arm(s): Nurse-led care | Intervention Type: BEHAVIORAL; Name: Routine care; Assigned to Arm(s): Nurse-led care, Routine care
C: Arm Label: Assessment-only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: BioBehavioral Intervention | Intervention Type: BEHAVIORAL; Name: BioBehavioral Intervention; Assigned to Arm(s): Intervention
D: Arm Label: Peer Support Program; Type: EXPERIMENTAL; Interventions: Behavioral: Peer Support Program | Arm Label: Wait-list Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer Support Program; Assigned to Arm(s): Peer Support Program

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Study on the Tailored Intervention Strategy of Childhood Obesity Based on Monitoring Physical Activities and Dietary Behaviors
Brief Summary: The project aims at developing the tailored intervention strategy of childhood obesity based on monitoring physical activities with accelerometer and dietary behaviors using diary. It probably raise the passion of obese children to control weight, form healthy life style, be effective in sustaining weight loss and early prevent adulthood diseases.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity guidance, Behavioral: Health education | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity guidance; Assigned to Arm(s): Intervention | Intervention Type: BEHAVIORAL; Name: Health education; Assigned to Arm(s): Intervention
B: Arm Label: Tailored intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Monitoring and Tailored prescription, Behavioral: General Health Education | Arm Label: Happy 10 exercise group; Type: EXPERIMENTAL; Interventions: Behavioral: Happy 10 program, Behavioral: General Health Education | Arm Label: Nutrition education group; Type: EXPERIMENTAL; Interventions: Behavioral: Specified nutrition education, Behavioral: General Health Education | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Monitoring and Tailored prescription; Assigned to Arm(s): Tailored intervention group | Intervention Type: BEHAVIORAL; Name: Happy 10 program; Assigned to Arm(s): Happy 10 exercise group | Intervention Type: BEHAVIORAL; Name: Specified nutrition education; Assigned to Arm(s): Nutrition education group | Intervention Type: BEHAVIORAL; Name: General Health Education; Assigned to Arm(s): Happy 10 exercise group, Nutrition education group, Tailored intervention group
C: Arm Label: School-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Trial of Activity for Adolescent Girls (TAAG) | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Trial of Activity for Adolescent Girls (TAAG); Assigned to Arm(s): School-based intervention
D: Arm Label: School-based intervention; Type: EXPERIMENTAL; Interventions: Behavioral: School intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School intervention; Assigned to Arm(s): School-based intervention

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Brief Summary: This study evaluates the product Walkadoo to determine whether it effectively increases walking behavior in healthy adults.


Options:
A: Arm Label: Short breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short breaks | Arm Label: Long breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Long breaks | Intervention Type: BEHAVIORAL; Name: Short breaks; Assigned to Arm(s): Short breaks | Intervention Type: BEHAVIORAL; Name: Long breaks; Assigned to Arm(s): Long breaks
B: Arm Label: Sitting time Change Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Sitting time Change Intervention | Arm Label: Active Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Sitting time Change Intervention; Assigned to Arm(s): Sitting time Change Intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Walkadoo | Intervention Type: BEHAVIORAL; Name: Walkadoo; Assigned to Arm(s): Intervention
D: Arm Label: High intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Low intensity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): High intensity intervention group, Low intensity intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of the Walking Intervention Walkadoo: A Randomized Controlled Pilot Trial in an Employee Population
Brief Summary: This study evaluates the product Walkadoo to determine whether it effectively increases walking behavior in healthy adults.


Options:
A: Arm Label: Short breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Short breaks | Arm Label: Long breaks; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Long breaks | Intervention Type: BEHAVIORAL; Name: Short breaks; Assigned to Arm(s): Short breaks | Intervention Type: BEHAVIORAL; Name: Long breaks; Assigned to Arm(s): Long breaks
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: ALIVE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ALIVE; Assigned to Arm(s): Intervention
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Walkadoo | Intervention Type: BEHAVIORAL; Name: Walkadoo; Assigned to Arm(s): Intervention
D: Arm Label: tailored group; Type: EXPERIMENTAL; Interventions: Behavioral: Start to stand | Arm Label: generic group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: generic advice | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Start to stand; Assigned to Arm(s): tailored group | Intervention Type: BEHAVIORAL; Name: generic advice; Assigned to Arm(s): generic group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Identification and Intervention for Dementia in Elderly Africans (IDEA) Study: CST Trial
Brief Summary: This trials of cognitive stimulation therapy (CST) in Tanzania is part of the larger Identification and Intervention for Dementia in Elderly Africans (IDEA) study.

The overall aim of the IDEA study is to set up and evaluate sustainable programmes to facilitate diagnosis of, and therapy for, people with dementia led by local communities in sub-Saharan Africa. We aim seek to improve quality of life for people with dementia and their caregivers.

Within this trial of CST, we hypothesise that CST can significantly improve the quality of people with dementia and their carers living in Africa


Options:
A: Arm Label: CST intervention; Type: EXPERIMENTAL; Interventions: Behavioral: CST Intervention | Arm Label: Group 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: CST Intervention; Assigned to Arm(s): CST intervention
B: Arm Label: Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Stimulation | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Cognitive Stimulation; Assigned to Arm(s): Intervention Group
C: Arm Label: 1; Type: N/A; Interventions: Procedure: Magnetic Resonance Imaging (MRI), Procedure: Positron Emission Tomography (PET), Procedure: Lumbar Puncture (LP) | Arm Label: 2; Type: N/A; Interventions: Procedure: Magnetic Resonance Imaging (MRI), Procedure: Positron Emission Tomography (PET), Procedure: Lumbar Puncture (LP) | Arm Label: 3; Type: N/A; Interventions: Procedure: Magnetic Resonance Imaging (MRI), Procedure: Positron Emission Tomography (PET), Procedure: Lumbar Puncture (LP) | Intervention Type: PROCEDURE; Name: Magnetic Resonance Imaging (MRI); Assigned to Arm(s): 1, 2, 3 | Intervention Type: PROCEDURE; Name: Positron Emission Tomography (PET); Assigned to Arm(s): 1, 2, 3 | Intervention Type: PROCEDURE; Name: Lumbar Puncture (LP); Assigned to Arm(s): 1, 2, 3
D: Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Individual Cognitive Stimulation Therapy; Type: EXPERIMENTAL; Interventions: Other: Individual Cognitive Stimulation Therapy Program | Intervention Type: OTHER; Name: Individual Cognitive Stimulation Therapy Program; Assigned to Arm(s): Individual Cognitive Stimulation Therapy

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy: a Multicentre, Double-blind, Double-dummy, Randomized Controlled Trial
Brief Summary: -IgA nephropathy is the most common primary glomerular disease in China, Huangkui Capsule is a single medicament of traditional Chinese medicine consists of Abelmoschus manihot and has been widely used to treat kidney disease. The purpose of this study is to evaluate the safety and efficacy of Abelmoschus manihot for treating IgA nephropathy in large scale samples with long time take.


Options:
A: Arm Label: Control Group; Type: EXPERIMENTAL; Interventions: Drug: Immunosuppressants, Other: Optimized Supportive Care, Other: Yi-Qi-Qing-Jie herbal compound placebo | Arm Label: YQF Group; Type: EXPERIMENTAL; Interventions: Drug: The Yi-Qi-Qing-Jie herbal compound, Drug: Immunosuppressants, Other: Optimized Supportive Care | Intervention Type: DRUG; Name: The Yi-Qi-Qing-Jie herbal compound; Assigned to Arm(s): YQF Group | Intervention Type: DRUG; Name: Immunosuppressants; Assigned to Arm(s): Control Group, YQF Group | Intervention Type: OTHER; Name: Optimized Supportive Care; Assigned to Arm(s): Control Group, YQF Group | Intervention Type: OTHER; Name: Yi-Qi-Qing-Jie herbal compound placebo; Assigned to Arm(s): Control Group
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Valsartan, Drug: Placebo | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Valsartan, Drug: Probucol | Intervention Type: DRUG; Name: Valsartan; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Probucol; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 1
C: Arm Label: Abelmoschus manihot (AM); Type: EXPERIMENTAL; Interventions: Drug: Abelmoschus manihot | Arm Label: Losartan; Type: EXPERIMENTAL; Interventions: Drug: Losartan | Intervention Type: DRUG; Name: Losartan; Assigned to Arm(s): Losartan | Intervention Type: DRUG; Name: Abelmoschus manihot; Assigned to Arm(s): Abelmoschus manihot (AM)
D: Intervention Type: DRUG; Name: Telmisartan; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Combination of Telmisartan and Ramipril; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Ramipril; Assigned to Arm(s): N/A

Answer: C